Anteo Diagnostics raises $5.5M to accelerate development of new...

Anteo Diagnostics raises $5.5M to accelerate development of new products

Monday, December 16, 2013 by Proactive Investors

Anteo Diagnostics has raised $5.5 million to accelerate development and commercialisation of new products.
Anteo Diagnostics has raised $5.5 million to accelerate development and commercialisation of new products.
Anteo Diagnostics (ASX: ADO) has raised $5.5 million to bring forward the development and commercialisation of products from two new patents to three years from seven years.

These patents complement the existing Mix&Go product portfolio and expand the protected areas of application to bioseparations, drug screening, drug delivery and areas outside the health care industry.

The funds were raised through a placement of 44 million shares priced at $0.125 each to a number of institutional and private investors.

Mix&Go is a “molecular glue” used in life sciences, pathology tests and point-of-care diagnostics to help identify and detect diseases more reliably and earlier.

http://www.proactiveinvestors.com.au/companies/news/51180/anteo-diagnostics-raises-55m-to-accelerate-development-of-new-products-51180.html